FDA approved a new clinician programmer for the company's implantable pain pump, as well as a series of recent design changes aimed at improving the pump s a pain management device.
The company enrolled the first patient in a postmarket study of its Evolve workflow therapy to standardize guidance for physicians.
Through the process of electrochemical etching, researchers created a nanotextured material for stainless steel surfaces that can kill bacteria without harming cells.
Unlike traditional DBS systems that are built from pacemaker technology, this device is modeled from cochlear implant technology and the precise stimulation of auditory nerves it uses to replicate hearing.
A team of researchers are working on an implantable device that would communicate with an external control module and glasses.
A Chicago startup that seeks to 3-D print human hearts for transplantation has added to its scientific advisory board of heavy hitters. But just how close is the company to producing its first viable heart?
FDA cleared Cianna Medical's Savi Scout reflector for breast cancer conservation surgery without restrictions on the length of time the implant can remain in the breast.
The company now has CE mark for its Intellis platform for both Spinal Cord Stimulation and Peripheral Nerve Stimulation as an aid in the management of certain types of chronic pain.
The Gore Excluder AAA Endoprosthesis, used to seal off abdominal aortic aneurysms, launched in Europe 20 years ago. Find out how the product has evolved over the past two decades.
Researchers are pioneering technology that could converge to enable pacemakers to be powered by longer-lasting sustainable energy.
Len Czuba, president of Czuba Enterprises, shares tips about developing implantable devices, and the keys to sourcing the best materials without spending a fortune.
After pausing its trials for its CardiAQ transcatheter mitral valve replacement earlier this year, Edwards Lifesciences announced implants are now being performed. Implants of the CardiAQ transcatheter mitral valve system are underway again. Early this year, transcatheter aortic valve replacement (...
Researchers have shown that the company’s in-development leadless pacemaker successfully delivers anti-tachycardia pacing and works in tandem with the subcutaneous ICD. What’s next for the technology?
Edwards Lifesciences posted U.S. transcatheter aortic valve revenue that impressed industry analysts. Here are the factors that buoyed sales and what management expects for the near future. Numerous factors, including faster growth from new hospitals, drove Edwards Lifesciences' strong first...